Parabellum Investments (UK) acquired Brussels-based anti-counterfeit drug specialist Advanco, marking the middle-market private equity firm's foray into the drug market.
Advanco is a Belgium-based IT firm that develops software products offering solutions such as hardware-integrated open serialization to sectors including cosmetics and pharma.